Journals Library

An error occurred retrieving publication content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

This study showed that a trial of a mobile app with peer support and clinical triage to monitor early warning signs of schizophrenia to detect and prevent relapse is feasible.

{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Andrew I Gumley 1,*, Simon Bradstreet 1, John Ainsworth 2, Stephanie Allan 1, Mario Alvarez-Jimenez 3,4, Maximillian Birchwood 5, Andrew Briggs 6, Sandra Bucci 2,7, Sue Cotton 3, Lidia Engel 8, Paul French 9, Reeva Lederman 10, Shôn Lewis 2,7, Matthew Machin 11, Graeme MacLennan 12, Hamish McLeod 1, Nicola McMeekin 1, Cathy Mihalopoulos 8, Emma Morton 13, John Norrie 14, Frank Reilly 15, Matthias Schwannauer 16, Swaran P Singh 5, Suresh Sundram 17, Andrew Thompson 3,5, Chris Williams 1, Alison Yung 2, Lorna Aucott 12, John Farhall 18,19, John Gleeson 20

1 Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
2 Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
3 Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia
4 Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia
5 Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK
6 Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK
7 Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK
8 School of Health and Social Development, Deakin University, Melbourne, VIC, Australia
9 Department of Nursing, Manchester Metropolitan University, Manchester, UK
10 School of Computing and Information Systems, Melbourne School of Engineering, University of Melbourne, Melbourne, VIC, Australia
11 Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
12 Health Services Research Unit, University of Aberdeen, Aberdeen, UK
13 Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
14 Usher Institute, University of Edinburgh, Edinburgh, UK
15 Scottish Recovery Network, Glasgow, UK
16 School of Health in Social Science, University of Edinburgh, Edinburgh, UK
17 Department of Psychiatry, Monash University, Melbourne, VIC, Australia
18 Department of Psychology and Counselling, La Trobe University, Melbourne, VIC, Australia
19 NorthWestern Mental Health, Melbourne, VIC, Australia
20 Healthy Brain and Mind Research Centre, Australian Catholic University, Melbourne, VIC, Australia
* Corresponding author Email: andrew.gumley@glasgow.ac.uk

Declared competing interests of authors: Andrew I Gumley reports personal fees from the University of Manchester, the University of Exeter and the British Association for Behavioural & Cognitive Psychotherapies (BABCP) (Accrington, UK), and other interests with NHS Education for Scotland outside the submitted work. John Ainsworth reports other interests with Affigo CIC (Manchester, UK) outside the submitted work. Sandra Bucci is a director of Affigo CIC, a not-for-profit social enterprise company spun out of the University of Manchester in December 2015 to enable access to social enterprise funding and to promote ClinTouch, a symptom-monitoring app, to the NHS and public sector. Andrew Briggs reports personal fees from Bayer (Leverkusen, Germany), Merck Sharp & Dohme (Kenilworth, NJ, USA), Janssen Pharmaceutica (Beerse, Belgium), Novartis (Basel, Switzerland), SWORD Health (Porto, Portugal), Amgen Inc. (Thousand Oaks, CA, USA) and Daiichi Sankyo (Tokyo, Japan) outside the submitted work. John Farhall reports grants from the National Health and Medical Research Council (Australia) during the conduct of the study and other interests with Melbourne Health (NorthWestern Mental Health, Parkville, VIC, Australia) outside the submitted work. Shôn Lewis reports grants from the Medical Research Council, non-financial support from Affigo CIC and personal fees from XenZone plc (Manchester, UK) outside the submitted work. Cathy Mihalopoulos reports grants from National Health and Medical Research Council (Australia) during the conduct of the study. John Norrie reports grants from the University of Aberdeen and the University of Edinburgh during the conduct of the study and declares membership of the following NIHR boards: CPR Decision Making Committee (2016), HTA Commissioning Board (2010–16), HTA Commissioning Sub-Board (EOI) (2012–16), HTA Funding Boards Policy Group (2016), HTA General Board (2016–19), HTA Post-Board funding teleconference (2016–19), NIHR CTU Standing Advisory Committee (2017–present), NIHR HTA and EME Editorial Board (2014–19) and Pre-exposure Prophylaxis Impact Review Panel (2017–present). Paul French is a member of the HTA Mental Health Prioritisation Panel (2017–present). Chris Williams reports grants from NIHR during the conduct of the study (HTA 10/104/34 BEAT-IT: a randomised controlled trial comparing a behavioural activation treatment for depression in adults with learning disabilities with attention control; NIHR multicentre RCT of a group psychological intervention for postnatal depression in British mothers of South Asian Origin: RP-PG-0514-20012: Integrated therapist and online CBT for depression in primary care); other from Five Areas Ltd (Clydebank, UK) outside the submitted work; and that he has twice been president of the British Association for Behavioural & Cognitive Psychotherapies, the lead body for cognitive–bahavioural therapy in the UK. This body aims to advocate use of evidence-based delivery of cognitive–bahavioural therapy.

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Crossmark status check

Report Content

The full text of this issue is available as a PDF document from the Toolkit section on this page.

The full text of this issue is available as a PDF document from the Toolkit section on this page.

If you would like to receive a notification when this project publishes in the NIHR Journals Library, please submit your email address below.

Responses to this report

No responses have been published.

 

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors.  Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

By submitting your response, you are stating that you agree to the terms & conditions

An error has occurred in processing the XML document